BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 9551412)

  • 1. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
    Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
    Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
    Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():53-9. PubMed ID: 10682072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
    Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Neri L; Viglino G; Cappelletti A; Gandolfo C; Cavalli PL
    Adv Perit Dial; 2000; 16():174-6. PubMed ID: 11045287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.